SUBSCRIBE
SUBSCRIBE
News   Business

Protein Sciences Facing Possible Bankruptcy; Company Wins $35 Million Flu Vaccine Contract

June 24, 2009 | 
1 min read
Bookmark and Share

NYT -- A small biotechnology company facing possible bankruptcy and liquidation has been awarded a $35 million federal contract to develop a faster way to make vaccines for pandemic influenza.
Alliances
MORE ON THIS TOPIC
Illustration of a syringe and medicine bottle with some broken glass
Manufacturing
Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site
December 2, 2025
 · 
6 min read
 · 
Nick Paul Taylor
A piggy bank crammed with $100 bills on a background of American cash
Series B
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Valneva Terminates 30 Amid Site Closure
December 1, 2025
 · 
92 min read
 · 
BioSpace Editorial Staff
Businessmen helping their friend climbing the rock, teamwork, partnership in business concept
Cell Therapy
6 Companies Hanging On in Cell Therapy
December 1, 2025
 · 
9 min read
 · 
Tristan Manalac